Insider · CIK 0001588467

DRACHMAN JONATHAN G

Reports to the SEC for 4 companies · BOTHELL, WA

sec.gov

Transactions

Companies

Filings

CIK

0001588467

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,300 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,415 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,531 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,016 sh	—	—	0
2024-03-08	Harpoon Therapeutics, Inc.A Award	Director	AAward	+415 sh	—	—	5,415
2023-11-27	Harpoon Therapeutics, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,000
2022-08-02	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+350K sh	—	—	350,000
2022-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2021-11-10	Calithera Biosciences, Inc.P Purchase	Director	PPurchase	+200K sh	$0.86	+$172K	200,000
2021-10-26	NGNENeurogene Inc.G Gift	Director, President and CEO	GGift	+75K sh	—	—	100,000
2021-10-26	NGNENeurogene Inc.G Gift	Director, President and CEO	GGift	+75K sh	—	—	100,000
2021-10-26	NGNENeurogene Inc.G Gift	Director, President and CEO	GGift	−75K sh	—	—	2,198,686
2021-10-26	NGNENeurogene Inc.G Gift	Director, President and CEO	GGift	−75K sh	—	—	2,198,686
2021-08-25	NGNENeurogene Inc.P Purchase	Director, President and CEO	PPurchase	+25K sh	$6.45	+$161K	25,000
2021-08-25	NGNENeurogene Inc.P Purchase	Director, President and CEO	PPurchase	+25K sh	$6.45	+$161K	25,000
2021-08-24	NGNENeurogene Inc.P Purchase	Director, President and CEO	PPurchase	+100K sh	$6.11	+$611K	2,348,686
2021-08-03	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+400K sh	—	—	400,000
2021-06-11	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-06-04	NGNENeurogene Inc.P Purchase	Director, President and CEO	PPurchase	+10K sh	$9.61	+$96.1K	2,248,686
2021-06-03	NGNENeurogene Inc.P Purchase	Director, President and CEO	PPurchase	+40K sh	$9.48	+$379K	2,238,686
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2020-08-10	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+420K sh	—	—	420,000
2020-06-09	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-05-28	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+2,880 sh	—	—	2,880
2020-05-28	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2019-12-20	NGNENeurogene Inc.P Purchase	Director, President and CEO	PPurchase	+119K sh	$8.40	+$1M	2,198,686
2019-11-12	NGNENeurogene Inc.C Conversion	Director, President and CEO	CConversion	−12.6K sh	—	—	0
2019-11-12	NGNENeurogene Inc.C Conversion	Director, President and CEO	CConversion	+1.26M sh	—	—	2,079,639
2019-09-11	NGNENeurogene Inc.P Purchase	Director, President and CEO	PPurchase	+136K sh	$3.30	+$450K	584,428
2019-09-10	NGNENeurogene Inc.P Purchase	Director, President and CEO	PPurchase	+36.7K sh	$3.08	+$113K	447,992
2019-09-09	NGNENeurogene Inc.P Purchase	Director, President and CEO	PPurchase	+76.8K sh	$2.85	+$219K	411,250
2019-08-31	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.65M sh	—	—	1,650,000
2019-08-08	NGNENeurogene Inc.A Award	Director, President and CEO	AAward	+7,428 sh	—	—	7,428
2019-08-08	NGNENeurogene Inc.A Award	Director, President and CEO	AAward	+334K sh	—	—	334,428
2019-08-08	NGNENeurogene Inc.A Award	Director, President and CEO	AAward	+568K sh	—	—	568,039
2019-08-08	NGNENeurogene Inc.A Award	Director, President and CEO	AAward	+12.6K sh	—	—	12,616
2019-06-03	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2019-05-30	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2019-02-07	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+4,266 sh	—	—	4,266
2018-05-31	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2018-03-20	Seagen Inc.Incentive Stock Option (right to buy)M Exercise/Conversion	CMO & EVP, R & D	MExercise/Conversion	−3,831 sh	—	—	0
2018-03-20	Seagen Inc.Incentive Stock Option (right to buy)M Exercise/Conversion	CMO & EVP, R & D	MExercise/Conversion	−6,468 sh	—	—	0
2018-03-20	Seagen Inc.M Exercise/Conversion	CMO & EVP, R & D	MExercise/Conversion	+7,000 sh	$10.61	+$74.3K	201,973
2018-03-20	Seagen Inc.M Exercise/Conversion	CMO & EVP, R & D	MExercise/Conversion	+13.7K sh	$12.00	+$165K	194,973
2018-03-20	Seagen Inc.M Exercise/Conversion	CMO & EVP, R & D	MExercise/Conversion	+6,468 sh	$15.46	+$100K	181,233
2018-03-20	Seagen Inc.M Exercise/Conversion	CMO & EVP, R & D	MExercise/Conversion	+3,831 sh	$26.10	+$100K	174,765
2018-03-20	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	CMO & EVP, R & D	MExercise/Conversion	−7,000 sh	—	—	0
2018-03-20	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	CMO & EVP, R & D	MExercise/Conversion	−13.7K sh	—	—	45,000

Recent filings

Accepted (ET)
Mar 114
DRACHMAN JONATHAN G0000950170-24-029434
SEC(opens sec.gov)
Nov 284
DRACHMAN JONATHAN G0001209191-23-056795
SEC(opens sec.gov)
Jun 234
DRACHMAN JONATHAN G0001209191-23-039407
SEC(opens sec.gov)
Aug 44
DRACHMAN JONATHAN G0001209191-22-044432
SEC(opens sec.gov)
Jun 244
DRACHMAN JONATHAN G0001209191-22-039325
SEC(opens sec.gov)
Feb 145
DRACHMAN JONATHAN G0001209191-22-009562
SEC(opens sec.gov)
Nov 104
DRACHMAN JONATHAN G0000899243-21-044150
SEC(opens sec.gov)
Aug 264
DRACHMAN JONATHAN G0001209191-21-053544
SEC(opens sec.gov)
Aug 54
DRACHMAN JONATHAN G0001209191-21-049919
SEC(opens sec.gov)
Jun 144
DRACHMAN JONATHAN G0000899243-21-023541
SEC(opens sec.gov)
Jun 74
DRACHMAN JONATHAN G0001209191-21-038690
SEC(opens sec.gov)

Companies

Address

21823 30TH DRIVE SE

BOTHELL, WA, 98021